Regarding the survival benefit, the difference did not reach statistical significance: the median survival was 42 days in the PER-treated group compared to 39 days in the control group (Log-rank p = 0.34) (Supplementary Fig. 27c ).
1
0.3400
0.3400
Regarding the survival benefit, the difference did not reach statistical significance: the median survival was 42 days in the PER-treated group compared to 39 days in the control group (Log-rank p = 0.34) (Supplementary Fig. 27c ).